Register for our free email digests:
iRhythm Technologies, Inc.
http://www.irhythmtech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From iRhythm Technologies, Inc.
Outlook 2021: Medtechs Must Look To Late 2021 And 2022 For A Return To Normal Times
Delivering innovation is still the driving force for medtechs intent on growing in the market, regardless of COVID-19, the disruptive effects of which have intensified with the appearance of new variants, says Jefferies Healthcare equity analyst Raj Denhoy.
Philips Extends Leadership In Patient Monitoring By Buying BioTelemetry For $2.8Bn
Philips is already the leader in hospital patient monitoring and adding BioTelemetry will make it also the top provider of ambulatory cardiac diagnostics and monitoring systems.
UK’s NICE Backs Interim Funding For 14-Day Ambulatory Heart Monitoring Tech
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices